Posts

USC medical school dean appointed to CIRM board

Carolyn C. Meltzer, MD, dean of the Keck School of Medicine of USC, has been app...

Q&A: How AI affects kids’ creativity

Shortly after artificial intelligence models including Midjourney and OpenAI’s D...

Engineered DNA ‘warhead’ targets a common cancer mutation

Tumour protein P53 (TP53) plays an important role in suppressing the growth of t...

Both high performance and stability were achieved with ...

 Through joint research with Professor Chul-jin Ahn’s team at Changwon National ...

Combining simulations and experiments to get the best o...

Osaka, Japan – The compound of iron and aluminum with the chemical formula Fe3Al...

Gerresheimer Increases the Capabilities of Medical Syst...

Gerresheimer, the maker of innovative systems and solutions and a partner to the...

AstraZeneca-Daiichi’s Enhertu Phase 3 Trial Demonstrate...

Daiichi Sankyo and AstraZeneca have applied to the FDA for their second-generati...

Neuren Phase 2 Study Shows Pitt Hopkins Syndrome Promise

Neuren Pharmaceuticals revealed key outcomes from its Phase 2 study of NNZ-2591 ...

Asahi Kasei offers to buy Sweden’s Calliditas for $1.04bn

Asahi Kasei has made a public cash offer for the acquisition of all shares in Ca...

Helsinn and Angelini Pharma renew AULIN and MESULID di...

Helsinn Group has renewed an agreement with Angelini Pharma for the commercialis...

QUT team receives US DoD funding for Parkinson’s treatment

Scientists of QUT have secured A$4m ($2.65m) grant from the US DoD for developin...

Vasomune wins FDA fast track designation for lung condi...

Currently in a Phase IIa study, AV-001 is being co-developed with AnGes for the ...

Self-amplifying RNA and vaccine innovation: getting fro...

Biomanufacturers using self-amplifying RNA, or saRNA, could enjoy significant ad...

Biotech’s road to recovery with 46% increase in Q1 vent...

Investor optimism in biotech has increased due to the expected lowering of inter...

J&J expands atopic dermatitis scope with $1.25bn Numab ...

J&J has made its second dermatology deal this month, adding Numab’s bispecific a...

How logistics service providers add value for pharma co...

Logistics service providers (LSPs) can help pharma companies achieve their suppl...